Anthony Prentice's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 3,940 Restricted Stock Unit done . Disclosure was reported to the exchange on July 25, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 3,940 | 47,289 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 3,940 | 13,800 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 1.47 per share. | 25 Jul 2022 | 1,698 | 12,102 | - | 1.5 | 2,496 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Former Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 4,576 | 14,436 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Former Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 4,576 | 68,642 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Former Chief Product Officer | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 01 Jul 2022 | 1,828 | 12,608 | - | 1.3 | 2,411 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 2.18 per share. | 28 Apr 2022 | 1,691 | 9,860 | - | 2.2 | 3,688 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 3,940 | 51,229 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 3,940 | 11,551 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 127,114 | 127,114 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 73,218 | 73,218 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 28 Jan 2022 | 2,021 | 7,611 | - | 2.8 | 5,743 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 3,940 | 55,169 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 3,940 | 9,632 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 151,110 | 151,110 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 39,211 | 39,211 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 17,141 | 17,141 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 3,940 | 3,940 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 3,940 | 59,109 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 8.09 per share. | 25 Oct 2021 | 1,620 | 2,320 | - | 8.1 | 13,106 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 63,049 | 63,049 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 42,033 | 42,033 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 1,733,674 | 1,733,674 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 449,871 | 449,871 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Anthony Prentice | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 196,666 | 196,666 | - | - | Employee Stock Option (Right to Buy) |